New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Take the survey

›ETF Issuers›Mirae Asset Global Investments›261070

261070

Mirae Asset TIGER KOSDAQ150 BIOTECH ETF

Passive ETF Equity

Not rated

The 261070 Exchange Traded Fund (ETF) is provided by Mirae Asset Global Investments. It is built to track an index: KOSDAQ 150 Bio Technology Index. The 261070 ETF provides physical exposure, so by buying it you actually own parts of all the 26 underlying holdings. This share class generates a stream of income by distributing dividends.

₩13,870

-₩395 (-2.77%) today

12:00 AM 08/12/26 Closed

1D price range

₩13,620₩14,145

52W price range

₩10,057.75₩22,445.95

YTD Perf.

-20.38%

YTD Flows

Annualized volatility

Fund AuM

€40M

Share class AuM

€40M

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

KR7261070007

TER

0.3%

Inception date

12/15/2016

Issuer

Mirae Asset Global Investments

Benchmark

KOSDAQ 150 Bio Technology Index

Replication method

Dividend policy

Distributing

Compare similar ETFs

No content available for this fund

API

PerformanceDec 30, 2025 - Aug 11, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 06/30/26

Healthcare

88.25%

Industrials

9.77%

Consumer Non-Cyclicals

1.89%

Latest 261070 news

No content available for this fund

FAQ about 261070

261070 is a Passive ETF. This ETF provides exposure to Large and Mid-Cap South Korean Biotechnology Equities.

261070 tracks the KOSDAQ 150 Bio Technology Index - KRW, through a full replication replication method.

261070 carries a total expense ratio (TER) of 0.3%, indicating the annual cost for holding the fund.

261070 was introduced to the market on December 15, 2016. It trades on Tanzania, United Republic of, among other exchanges

Mirae Asset TIGER KOSDAQ150 BIOTECH ETF, 261070, is provided by Mirae Asset Global Investments. Learn more about Mirae Asset Global Investments here.

261070 oversees €40M in assets as of August 11, 2026.

261070 follows a distributing dividend policy, meaning it pays out income to investors. As of August 11, 2026, its 12-month trailing yield was 0.70%.

As of June 30, 2026, 261070 has significant geographic allocations in Republic of Korea.

As of June 30, 2026, 261070 focuses largely on Healthcare, Industrials and Consumer Non-Cyclicals.

As of June 30, 2026, 261070 holds 26 positions in its portfolio, with 85.30% of assets concentrated in its top 15 holdings.

As of June 30, 2026, 261070 top three holdings include Alteogen, Inc., HLB Co., Ltd. and ABL Bio, Inc..

The base currency of 261070 is KRW.

Top 10 holdings

Data as of 06/30/26

Alteogen, Inc.

23.51%

HLB Co., Ltd.

9.77%

ABL Bio, Inc.

6.61%

Peptron, Inc.

6.35%

LigaChem Biosciences, Inc.

6.23%

SAM CHUN DANG PHARM Co., Ltd.

5.01%

D&D Pharmatech Co., Ltd.

4.86%

OliX Pharmaceuticals, Inc.

4.03%

PharmaResearch Co., Ltd.

3.96%

Voronoi, Inc.

3.18%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

The ETF Industry Is Evolving Fast

Mirae Asset TIGER KOSDAQ150 BIOTECH ETF

FAQ about 261070

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US